BTIG Research Begins Coverage on Quantinuum (NASDAQ:QNT)

BTIG Research initiated coverage on shares of Quantinuum (NASDAQ:QNT – Get Free Report) in a research report issued on Thursday, Marketbeat reports. The firm set a “buy” rating and a $60.00 price target on the stock. BTIG Research‘s target price indicates a potential upside of 69.49% from the stock’s current price.

Other research analysts also recently issued research reports about the company. Rosenblatt Securities reissued a “buy” rating and issued a $155.00 price target on shares of Quantinuum in a research note on Thursday, October 22nd. Cantor Fitzgerald decreased their price objective on Quantinuum from $90.00 to $55.00 and set an “overweight” rating for the company in a research note on Friday, November 6th. Sanford C. Bernstein reaffirmed a “hold” rating on shares of Quantinuum in a research note on Wednesday, August 12th. Needham & Company LLC dropped their price objective on Quantinuum from $100.00 to $60.00 and set a “buy” rating for the company in a report on Friday, November 6th. Finally, Jefferies Financial Group cut their target price on Quantinuum from $85.00 to $65.00 and set a “buy” rating on the stock in a research note on Friday, November 6th. Fourteen analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $80.21.

Get Our Latest Research Report on Quantinuum

Quantinuum Stock Performance

Shares of NASDAQ QNT opened at $35.40 on Thursday. Quantinuum has a 1 year low of $28.31 and a 1 year high of $86.79. The company has a 50-day simple moving average of $42.45.

Quantinuum (NASDAQ:QNT – Get Free Report) last posted its quarterly earnings results on Thursday, November 5th. The company reported ($0.29) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.99) by $0.70. The business had revenue of $9.05 million for the quarter. Analysts expect that Quantinuum will post -4.76 EPS for the current year.

Institutional Investors Weigh In On Quantinuum

Large investors have recently bought and sold shares of the company. CoreCap Advisors LLC acquired a new stake in Quantinuum in the third quarter worth $32,000. Fifth Third Bancorp grew its holdings in shares of Quantinuum by 1,530.2% in the 3rd quarter. Fifth Third Bancorp now owns 1,027 shares of the company’s stock valued at $49,000 after buying an additional 964 shares during the period. IFP Advisors Inc increased its position in shares of Quantinuum by 1,150.0% in the 3rd quarter. IFP Advisors Inc now owns 1,250 shares of the company’s stock valued at $60,000 after buying an additional 1,150 shares in the last quarter. GW&K Investment Management LLC bought a new stake in shares of Quantinuum in the 3rd quarter valued at $82,000. Finally, Russell Investments Group Ltd. acquired a new stake in Quantinuum during the 3rd quarter worth $97,000.

About Quantinuum

(Get Free Report)

Quantinuum develops quantum computers, software and cybersecurity products for businesses, researchers and government organizations. Its work includes trapped-ion quantum systems, tools for programming and managing quantum applications, and services focused on quantum chemistry and data security. The company was formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum, bringing together quantum hardware and software capabilities. Its offerings include the H-series quantum computers, the TKET software development kit and InQuanto, a platform for quantum chemistry research.

Featured Articles

Analyst Recommendations for Quantinuum (NASDAQ:QNT)

Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.